Nutrien stock has delivered a 53.8% total return over the past five years, and the current valuation now sits at an interesting crossroads, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to upside while broader checks paint a more mixed picture.
- Over five years, Nutrien has returned 53.8%, which puts recent gains front and center when assessing whether the current price still offers a margin of safety.
- US plans to invest US$500 million in domestic fertilizer production can support long term demand assumptions for companies like Nutrien, while policy shifts or additional capacity in the sector may pressure pricing power over time.
- The stock screens as undervalued in 4 of 6 valuation checks, which is a mixed picture rather than a clear bargain or clear overvaluation. You can see the breakdown in 4/6.
The issue now is whether Nutrien's current share price already reflects this setup, or if the intrinsic value estimate still leaves room for further upside.
Find out why Nutrien's 21.4% return over the last year is lagging behind its peers.
Is Nutrien a Bargain on Cash Flow?
The Discounted Cash Flow (DCF) approach values Nutrien by projecting future free cash flows and discounting them back to today. Nutrien generated about $2.0b of free cash flow over the latest twelve months, and the model assumes these cash flows grow and then level off rather than shrinking sharply.
On these assumptions, the 2 Stage Free Cash Flow to Equity model points to an intrinsic value of about CA$122 per share. Compared with the current share price, this implies the stock trades at roughly a 21.1% discount. In other words, the market price sits below what the cash flow profile alone would suggest. The US decision to commit US$500 million to domestic fertilizer capacity helps explain why some investors may be cautious, as added supply can matter for long term pricing, even if the DCF still points to a gap.
Overall, the Discounted Cash Flow analysis indicates Nutrien stock appears undervalued relative to its modeled cash generation.
Our Discounted Cash Flow (DCF) analysis suggests Nutrien is undervalued by 21.1%. Track this in your watchlist or portfolio, or discover 5 more high quality undervalued stocks.
Is Nutrien Fairly Priced on Earnings?
The P/E ratio is a practical way to look at Nutrien because earnings remain a core reference point for how the market is valuing the business today. Nutrien trades on a P/E of about 13.8x, which sits below the broader Chemicals industry average of roughly 21.7x and also below the peer group average of about 16.2x.
On Simply Wall St's model, a fair P/E for Nutrien, given its profile, is estimated at about 12.9x, which is only slightly under the current multiple. That small gap suggests the stock is not being priced at a steep discount or premium on earnings, even if the industry as a whole tends to trade higher. For investors, the P/E indicates that Nutrien is being valued close to what its earnings might justify rather than as a clear bargain or an obviously expensive stock.
Overall, Nutrien appears roughly fairly valued on its P/E multiple when compared with its tailored fair ratio and sector benchmarks.
See what the numbers say about this price — find out in our valuation breakdown.
The Nutrien Narrative: What Would Justify Today's Price?
Simply Wall St Narratives pick up where Nutrien's valuation puzzle leaves off by explaining which paths for Nutrien's future growth, margins and earnings would need to hold for the stock to be worth materially more or less than it is today, based on scenarios shared on the Community page. Each narrative links a fair value estimate to a specific set of potential catalysts and risks, so you can monitor over time which version of Nutrien's story appears to be unfolding.
The community is split on Nutrien, with one camp focusing on tighter fertilizer markets and capital returns, and the other on regulatory and demand risks.
Bull case: 15% undervalued
"Nutrien's investments in automation, precision ag, and efficiency position it to capture higher-margin, premium sales and expand net margins over time..."
Read the full Bull Case to see why Nutrien could be undervalued
Bear case: roughly fairly valued
"Accelerating global regulatory and consumer shifts toward sustainable and organic agriculture threaten to permanently reduce demand for conventional fertilizers, leading to persistent revenue headwinds..."
Read the full Bear Case to see why Nutrien could be overvalued
Do you think there's more to the story for Nutrien? Head over to our Community to see what others are saying!
The Bottom Line
For Nutrien, the Discounted Cash Flow (DCF) work suggests the stock is undervalued, with intrinsic value sitting meaningfully above the current share price. At the same time, the P/E and other checks point to pricing that is about right rather than a clear bargain, which keeps the overall valuation picture mixed rather than decisive. What really separates bulls and bears now is whether Nutrien can sustain attractive cash generation in the face of changing fertilizer supply, regulation and farming practices, or whether today’s discount simply reflects those risks accurately.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com